Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PARP7-mediated ADP-ribosylation of FRA1 promotes cancer cell growth by repressing IRF1- and IRF3-dependent apoptosis
Patrick Manetsch, Flurina Böhi, Kathrin Nowak, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 49
Open Access | Times Cited: 13

Showing 13 citing articles:

Loss of Parp7 increases type I interferon signalling and reduces pancreatic tumour growth by enhancing immune cell infiltration
Vinicius Kannen, Marit Rasmussen, Siddhartha Das, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
PARP7 inhibits type I interferon signaling to prevent autoimmunity and lung disease
Devon Jeltema, Kay Knox, Nicole Dobbs, et al.
The Journal of Experimental Medicine (2025) Vol. 222, Iss. 5
Open Access
α-Hederin causes ferroptosis in triple-negative breast cancer through modulating IRF1 to suppress GPX4
Xue Wu, Lingli Jin, Disuo Ren, et al.
Phytomedicine (2025) Vol. 141, pp. 156611-156611
Closed Access
PARP7 as a new target for activating anti-tumor immunity in cancer
K. Popova, Johannes Benedum, Magdalena Engl, et al.
EMBO Molecular Medicine (2025)
Open Access
PARP7 and nucleic acid-driven oncosuppression
Flavie Naulin, Emma Guilbaud, Lorenzo Galluzzi
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 11, pp. 1177-1179
Closed Access | Times Cited: 2
PARP enzymes and mono-ADP-ribosylation: advancing the connection from interferon-signalling to cancer biology
Barbara Morone, Giovanna Grimaldi
Expert Reviews in Molecular Medicine (2024) Vol. 26
Open Access | Times Cited: 2
Expanding the Perspective on PARP1 and Its Inhibitors in Cancer Therapy: From DNA Damage Repair to Immunomodulation
Flurina Böhi, Michael O. Hottiger
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1617-1617
Open Access | Times Cited: 1
Pathological and physiological roles of ADP-ribosylation: established functions and new insights
Karla L. H. Feijs, Nonso Josephat Ikenga, Roko Žaja
Biological Chemistry (2024) Vol. 405, Iss. 9-10, pp. 567-581
Closed Access | Times Cited: 1
Aberrant STING activation promotes macrophage senescence by suppressing autophagy in vascular aging from diabetes
Huiqing Ding, Quan Zhang, Rukai Yang, et al.
iScience (2024) Vol. 28, Iss. 1, pp. 111594-111594
Open Access | Times Cited: 1
Unleashing viral mimicry: A combinatorial strategy to enhance the efficacy of PARP7 inhibitors
Patrick Manetsch, Michael O. Hottiger
BioEssays (2024)
Open Access
Distinct Capabilities in NAD Metabolism Mediate Resistance to NAMPT Inhibition in Glioblastoma
Richard Perryman, Tsz Wing Chau, John DeFelice, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2054-2054
Open Access
PARP14 mediated SQSTM1/p62 cysteine ADP-ribosylation is counteracted by the SARS-CoV-2 macrodomain
David Kubon, Deena M. Leslie Pedrioli, Michael O. Hottiger
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Page 1

Scroll to top